BRCA2 and ovarian carcinoma: BRCA1 and BRCA2 mutations account for a considerable proportion of Chinese hereditary breast/ovarian cancer patients, and the penetrance of these two genes should be investigated because such investigations will be very important for the development of a preventive treatment strategy in China.